Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous MSC Infusion as Adjunct Treatment in Idiopathic Pulmonary Fibrosis
DRKS00008790Phase 2Not yet recruiting
- Sponsor
- Republican Research and Practical Center for Pulmonology and Tuberculosis
- Start
- Jul 2015
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2 trial of autologous mesenchymal stromal cells in idiopathic pulmonary fibrosis (IPF) (2 arms), sponsored by Republican Research and Practical Center for Pulmonology and Tuberculosis. Planned start Jul 2015; status: not yet recruiting.
02
Drugs
autologous mesenchymal stromal cells
03
Conditions
idiopathic pulmonary fibrosis (IPF)
Beyond the preview
Go deeper on DRKS00008790.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00008790.